Tryptophan

coagulation factor II, thrombin ; Homo sapiens







37 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34895068 Design of a protein-targeted DNA aptamer using atomistic simulation. 2021 Dec 11 1
2 29634247 Dynamic Consequences of Mutation of Tryptophan 215 in Thrombin. 2018 May 8 1
3 27435675 Structural Architecture of Prothrombin in Solution Revealed by Single Molecule Spectroscopy. 2016 Aug 26 1
4 20211924 Replacement of Phe274 with conserved residue Tyr274 for reactive center loop expulsion in antithrombin. 2011 Jun 1
5 20404340 Engineering thrombin for selective specificity toward protein C and PAR1. 2010 Jun 18 2
6 18585267 Tryptophan-contained peptide-functional nanomaterials as general spectrofluorometric reagents for enzyme. 2008 Jun 30 3
7 17284929 Lys, pro and trp are critical core amino acid residues recognized by FUM20, a monoclonal antibody against serine protease pan-fungal allergens. 2007 2
8 16641485 3-Nitrotyrosine as a spectroscopic probe for investigating protein protein interactions. 2006 May 1
9 17001711 Mapping the fluorophilicity of a hydrophobic pocket: synthesis and biological evaluation of tricyclic thrombin inhibitors directing fluorinated alkyl groups into the p pocket. 2006 Nov 1
10 17074754 Rapid kinetics of Na+ binding to thrombin. 2006 Dec 29 6
11 15771442 In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design. 2005 Mar 24 3
12 12794066 Roles of low specificity and cofactor interaction sites on thrombin during factor XIII activation. Competition for cofactor sites on thrombin determines its fate. 2003 Aug 22 1
13 14750503 A peptide isolated from alpha B-crystallin is a novel and potent inhibitor of platelet aggregation via dual prevention of PAR-1 and GPIb/V/IX. 2003 Dec 1
14 11297729 Intrinsic fluorescence changes and rapid kinetics of proteinase deformation during serpin inhibition. 2001 Apr 6 1
15 10739244 The crystal structures of human alpha-thrombin complexed with active site-directed diamino benzo[b]thiophene derivatives: a binding mode for a structurally novel class of inhibitors. 2000 Jan 1
16 10739383 Oxidation of human alpha-thrombin by the myeloperoxidase-H2O2-chloride system: structural and functional effects. 2000 Feb 1
17 10831587 Fluorescence properties and functional roles of tryptophan residues 60d, 96, 148, 207, and 215 of thrombin. 2000 Sep 22 2
18 9790668 Allosteric effects of a monoclonal antibody against thrombin exosite II. 1998 Oct 27 1
19 9351523 Molecular analysis of a compound heterozygote for hypoprothrombinemia and dysprothrombinemia (-G 7248/7249 and ARG 340 TRP). 1997 Sep 2
20 9361370 Impact of mutations at the P4 and P5 positions on the reaction of antithrombin with thrombin and elastase. 1997 Oct 15 1
21 7510689 Thrombin and thrombin receptor agonist peptide induce early events of T cell activation and synergize with TCR cross-linking for CD69 expression and interleukin 2 production. 1994 Mar 18 2
22 7526841 Thrombin-receptor agonist peptides, in contrast to thrombin itself, are not full agonists for activation and signal transduction in human platelets in the absence of platelet-derived secondary mediators. 1994 Oct 15 4
23 8383967 The N-terminal thrombin receptor fragment SFLLRN, but not catalytically inactive thrombin-derived agonists, activate U937 human monocytic cells: evidence for receptor hydrolysis in thrombin-dependent signalling. 1993 Mar 1 4
24 1354985 Prothrombin Salakta: substitution of glutamic acid-466 by alanine reduces the fibrinogen clotting activity and the esterase activity. 1992 Aug 25 2
25 1751488 Reconstitution of catalytically competent human zeta-thrombin by combination of zeta-thrombin residues A1-36 and B1-148 and an Escherichia coli expressed polypeptide corresponding to zeta-thrombin residues B149-259. 1991 Dec 17 4
26 1939071 Crystallographic analysis at 3.0-A resolution of the binding to human thrombin of four active site-directed inhibitors. 1991 Oct 25 1
27 2847349 Modification of human thrombin: effect on thrombomodulin binding. 1988 Jun 16 2
28 3196339 A hydrophobic site in human prothrombin present in a calcium-stabilized conformer. 1988 Nov 30 1
29 3567158 Prothrombin Tokushima, a replacement of arginine-418 by tryptophan that impairs the fibrinogen clotting activity of derived thrombin Tokushima. 1987 Feb 24 2
30 3584126 Antithrombin conformation and the catalytic role of heparin. I. Does cleavage by thrombin induce structural changes in the heparin-binding region of antithrombin? 1987 Jun 5 1
31 6693405 The heparin-binding site of antithrombin III. Identification of a critical tryptophan in the amino acid sequence. 1984 Jan 25 2
32 6865262 [Tryptophan loading test as a function parameter in liver diseases]. 1983 Mar 15 1
33 7126590 Radiation-induced changes in purified prothrombin and thrombin. 1982 Aug 23 1
34 7306521 Conformational differences between high clotting human alpha-thrombin and nonclotting gamma-thrombin. 1981 Nov 10 9
35 101250 Functional consequences of tryptophan modification in human fibrinogen. 1978 Sep 26 1
36 409714 Structure-function relationships in the interaction of alpha-thrombin with blood platelets. 1977 Oct 25 1
37 5534304 Tyrosine and tryptophan residues and amino groups in thrombin related to enzymic activities. 1970 Sep 29 1